A novel receptor for Apo2L/TRAIL contains a truncated death domain

Current Biology

Volumn 7, Issue 12, 1997, Pages 1003-1006

  Marsters, S A ^a   Sheridan, J P ^a   Pitti, R M ^a   Huang, A ^a   Skubatch, M ^a   Baldwin, D ^a   Yuan, J ^a   Gurney, A ^a   Goddard, A D ^a   Godowski, P ^a   Ashkenazi, A ^a  

^a GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 13144265771     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9822(06)00422-2     Document Type: Article

References (15)

1. Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, Ashkenazi A: Induction of apoptosis by Apo-2 Ligand, a new member of the tumor necrosis factor receptor family. J Biol Chem 1996, 271:12697-12690.
2. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, et al.: Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995, 3:673-682.
3. Pan G, O'Rourke K, Chinnaiyan AM, Gentz R, Ebner R, Ni J, et al.: The receptor for the cytotoxic ligand TRAIL. Science 1997, 276:111-113.
4. Sheridan JP, Marsters SA, Pitti RM, Gurney A, Skubatch M, Baldwin D, et al.: Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 1997, 277:818-821.
5. Pan G, Dixit VM: An antagonist decoy receptor and a new death domain-containing receptor for TRAIL Science 1997, 277:815-818.
6. Nagata S: Apoptosis by death factor. Cell 1997, 88:355-365.
7. Marsters S, Sheridan J, Donahue C, Pitti R, Gray C, Goddard A, et al.: Apo3, a new member of the tumor necrosis factor receptor family, contains a new death domain and activates apoptosis and NF-κB. Curr Biol 1996, 6:1669-1676.
8. Chinnaiyan AM, O'Rourke K, Yu GL, Lyons RH, Garg M, Duan DR, et al.: Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science 1996, 274:990-992.
9. Kitson J, Raven T, Jiang YP, Goeddel DV, Giles KM, Pun KT, et al.: A death-domain-containing receptor that mediates apoptosis. Nature 1996, 384:372-375.
10. Bodmer JL, Burns K, Schneider P, Hofmann K, Steiner V, Thome M, et al.: TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis receptor 1 and Fas (Apo-1/CD95). Immunity 1997, 6:79-88.
11. Tartaglia LA, Ayers TM, Wong G HW, Goeddel DV: A novel domain within the 55 kd TNF receptor signals cell death. Cell 1993, 74:845-853.
12. Marsters S, Pitti R, Donahue C, Ruppert S, Bauer K, Ashkenazi A: Activation of apoptosis by Apo-2 ligand is independent of FADD but blocked by CrmA. Curr Biol 1996, 6:750-752.
13. Mitelman F, Mertens F, Johansson B: A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nature Genet 1997, 15:417-474.
14. Ashkenazi A and Chamow SM: Immunoadhesins: An alternative to human monoclonal antibodies. Methods: a Companion to Methods in Enzymology 1995, 8:104-115.
15. Ashkenazi A, Marsters SA, Capon DJ, Chamow SM, Figari IS, Pennica D, et al.: Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin. Proc Natl Acad Sci USA 1991, 88:10535-10539.